Accueil   Agenda - News   Tout l'agenda Good, Better, Best – Building Your Program for Immunomodulating Therapeutics Symposium

Good, Better, Best – Building Your Program for Immunomodulating Therapeutics Symposium

 

Friday, October 18, 2019 | 8:30-17:00

Auditorium | Boehringer Ingelheim 
29 Avenue Tony Garnier
69007 Lyon, France

 

 

From vaccines to checkpoint inhibitors, immunomodulatory therapeutics represent a promising class of drugs for patients and developers alike, but bringing them to market demands a thoughtful program design that accounts for the unique challenges of biologic products.

 

Join a panel of experts from industry for a full day of stimulating presentations and case studies that highlight the key elements of a well-structured program, including optimal investigation of MoA with early in vitro data and cell-based assays and more.

 

PROGRAM

 

 

8:30 – 9:00

Welcome and coffee

 

9:00 – 9:15

Opening session

 

9:15 – 10:00

Human IgG transgenic mice to profile safety of immunomodulating molecules: Opportunities, challenges and HA feedback | Ulrike Hopfer, Hoffman La Roche

 

10:00 – 10:45

Use of model antigens to evaluate T cell-dependent immune stimulation in large animals | Philippe Ancian, Charles River

 

10:45 – 11:00

Break

 

11:00 – 11:45

Inclusion of exploratory PD biomarkers in first-in-human clinical trials adds value by providing information to confirm the mode of action of a candidate therapeutic | Russell Garland, Charles River

 

11:45 – 13:30

Networking lunch

 

13:30 – 14:15

Oncolytic viruses and personalized viral vector-based vaccines, recent progresses in anti-tumor virotherapy | Eric Quéméneur, Transgene

 

14:15 – 15:00

Investigation of immuno-oncology drug responsiveness in patient-derived xenografts combined with a humanized mouse model approach | Loreen Weichert, Charles River

 

15:00 – 15:30

Break

 

15.30 – 16.30

Roundtable: Do we understand enough when it comes to translational and the immunological safety assessment of immunotherapy/immunostimulatory drugs? | Jacques Descotes, Immunotoxicology Consulting Group

 

16:30 Closing remarks

 

More information about the event and registrer

Voir tout l'agenda

En poursuivant votre navigation sur notre site, vous acceptez l'utilisation des cookies et la collecte de vos données et informations personnelles par Lyonbiopôle, dans les finalités de mesurer le trafic sur le site Web, de fournir des statistiques et de vous proposer des contenus adaptés à vos centres d’intérets. Pour exercer vos droits d'accès, de rectification, d'opposition, de suppression et de portabilité, conformément au règlement général sur la protection des données (UE n°2016/679), vous etes informés que vous pouvez envoyer votre demande à dpo@lyonbiopole.com. Plus de détails sont disponibles en cliquant ici J'accepte